稳定型心绞痛患者腺苷受体激动剂负荷心肌灌注显像正常后的症状演变:RISE研究
RISE研究为前瞻性队列,纳入87例稳定胸痛成人,行锝-99m甲氧基异丁基异腈(Sestamibi)负荷心肌灌注显像(MPI)且结果正常,基线与3个月时填写西雅图心绞痛问卷。随访时躯体受限、心绞痛稳定度、心绞痛频率及疾病感知评分均显著改善,治疗满意度无显著变化,32%患者无心绞痛发作。
要点
- MPI正常后3个月内躯体功能、心绞痛稳定度与频率、疾病感知均显著改善。
- 治疗满意度评分无显著变化。
- 3个月随访时32%患者达到无心绞痛发作。
核心结论
- 稳定胸痛且MPI正常的患者短期内功能状态、生活质量及疾病感知显著改善。
研究设计与样本
- 前瞻性队列研究,在阿拉巴马大学伯明翰分校纳入87例来自急诊、住院及门诊的稳定胸痛成人,行锝-99m Sestamibi MPI且结果正常,基线与3个月随访填写西雅图心绞痛问卷。
主要发现
- 躯体受限评分平均提高14.2(95%CI 10.4-18.7,P<.001)。
- 心绞痛稳定度评分平均提高23.2(95%CI 17.1-29.4,P<.001)。
- 心绞痛频率评分平均提高10.9(95%CI 7.6-14.1,P<.001)。
- 疾病感知评分平均提高20.6(95%CI 16.5-24.7,P<.001)。
- 治疗满意度评分变化无统计学意义(-1.4,95%CI -4.7至1.8,P=.38);3个月随访时87例中28例(32%)无心绞痛。
关键数值与推荐
- 研究人群年龄60±12岁,40%为非裔美国人,70%为女性,29%患糖尿病。
临床怎么用
- 对稳定胸痛且MPI正常者,可预期短期症状与生活质量改善,后续诊断与治疗决策需结合症状演变综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Assessment of quality of life in patients with stable angina and normal gated single-photon emission computed tomography myocardial perfusion imaging (MPI) remains undefined. Symptom evolution in response to imaging findings has important implications on further diagnostic testing and therapeutic interventions. METHODS: Prospective cohort study was conducted at the University of Alabama at Birmingham enrolling 87 adult participants with stable chest pain from the emergency room, hospital setting, and outpatient clinics. Patients underwent MPI with technetium-99m Sestamibi and had a normal study. Participants filled out Seattle Angina Questionnaires initially and at 3-month follow-up. RESULTS: Among the 87 participants (60 ± 12 years; 40% African American, 70% women, 29% diabetes), the mean score increased by an absolute value of 14.2 [95% CI 10.4-18.7, P < .001] in physical limitation, 23.2 [95% CI 17.1-29.4, P < .001] in angina stability, 10.9 [95% CI 7.6-14.1, P < .001] in angina frequency, and 20.6 [95% CI 16.5-24.7, P < .001] in disease perception. There was no significant change in the mean score of treatment satisfaction [- 1.4, 95% CI - 4.7 to 1.8, P = .38]. At 3-month follow-up, 28 of 87 participants (32%) were angina free. CONCLUSIONS: Patients with stable chest pain and normal MPI experience significant improvement in functional status, quality of life, and disease perception in the short term.
引用
- McRee CW, Brice LR, Farag AA, et al. Evolution of symptoms in patients with stable angina after normal regadenoson myocardial perfusion imaging: The Radionuclide Imaging and Symptomatic Evolution study (RISE). J Nucl Cardiol. 2020. PMID: 32754894. doi:10.1007/s12350-020-02298-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。